Anglodom 1mg/ml Drop

About this Medicine

Anglodom 1mg/ml Drop helps treat indigestion, gastroesophageal reflux disease, nausea, and vomiting in children. It increases the movement of food through the stomach and intestines, thereby relieving bloating, fullness, and gastric discomfort. Anglodom 1mg/ml Drop is best given half an hour before each meal. If given after meals, it will still work but the absorption of the medicine may get affected. For young babies, the doctor may prescribe giving it four times each day. Wait for at least 4 hours between doses and give each dose just before a milk feed. The doses usually vary depending upon your child’s condition, body weight, and age. Never exceed the prescribed duration without consulting the doctor. If your child vomits within 30 minutes of the intake, repeat the same dose once your child calms down, but do not double dose if it is time for the next dose.This medicine may cause some minor and temporary side effects such as dry mouth, headache, drowsiness, stomach cramps, and diarrhea. Usually, these episodes subside once your child’s body adapts to the medicine. However, if these side effects persist or become bothersome for your child, report to the doctor without any delay.Your child’s doctor should be aware if your child has had any previous episodes of allergy, heart problem, a blood disorder, birth defects, airway obstruction, lung anomaly, gastrointestinal problem, skin disorder, liver impairment, and kidney malfunction. Being aware of your child’s entire medical history will help the doctor make critical dose alterations and plan your child’s overall treatment.

How it Works

Anglodom 1mg/ml Drop is a prokinetic. It works on the region in the brain that controls vomiting. It also acts on the upper digestive tract to increase the movement of the stomach and intestines, allowing food to move more easily through the stomach.

Key Facts

Chemical Class :: Benzimidazole Derivative|Habit Forming :: No|Therapeutic Class :: GASTRO INTESTINAL|Action Class :: Dopamine D2 Receptor Antagonists- Prokinetic Agents

Safety Overview